Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 44,373 | 44,707 | 39,570 | 43,771 | 40,706 |
| Cost of Goods | 1,513 | 979 | 1,017 | 1,603 | 1,133 |
| Gross Profit | 42,860 | 43,728 | 38,553 | 42,168 | 39,573 |
| Operating Expenses | 77,810 | 81,236 | 76,798 | 47,756 | 75,289 |
| Operating Income | -34,437 | -36,529 | -38,228 | -4,985 | -35,583 |
| Interest Expense | 4,547 | 4,817 | 4,865 | 5,065 | 2,533 |
| Other Income | 1,971 | 2,714 | 2,517 | 2,595 | -15,985 |
| Pre-tax Income | -37,013 | -38,632 | -40,576 | -7,455 | -54,101 |
| Income Tax | -523 | 69 | 401 | N/A | 415 |
| Net Income Continuous | -36,490 | -38,701 | -40,977 | -7,455 | -54,516 |
| Net Income | $-36,490 | $-38,701 | $-40,977 | $-7,455 | $-54,516 |
| EPS Basic Total Ops | -0.85 | -0.92 | -0.99 | -0.18 | -1.34 |
| EPS Basic Continuous Ops | -0.85 | -0.92 | -0.99 | -0.18 | -1.34 |
| EPS Diluted Total Ops | -0.85 | -0.92 | -0.99 | -0.18 | -1.34 |
| EPS Diluted Continuous Ops | -0.85 | -0.92 | -0.99 | -0.18 | -1.34 |
| EBITDA(a) | $-26,796 | $-54,951 | $-5,711 | $1,945 | $-30,028 |